Key facts
| Recalling firm | Becton, Dickinson and Company |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI code: 00690103210927 The non-invasive ForeSight oximeter cable is intended for use as an adjunct monitor of absolute regional hemoglobin oxygen saturation of blood under the sensors in individuals at risk for reduced flow or no flow ischemic states. The ForeSight Oximeter Cable is also intended to monitor relative changes of total hemoglobin of blood under the sensors. The ForeSight Oximeter Cable is intended to allow for the display of StO2 and relative change in total hemoglobin on the HemoSphere advanced monitor. |
| Classification | Class II |
| Recall number | Z-3250-2026 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | Due to incorrect switching of Channel 1 and 2 on the module and flag labels on the tissue oximetry cables. |
What this classification means
A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI code: 00690103210927 The non-invasive ForeSight oximeter cable is intended for use as an adjunct monitor of absolute regional hemoglobin oxygen saturation of blood under the sensors in individuals at risk for reduced flow or no flow ischemic states. The ForeSight Oximeter Cable is also intended to monitor relative changes of total hemoglobin of blood under the sensors. The ForeSight Oximeter Cable is intended to allow for the display of StO2 and relative change in total hemoglobin on the HemoSphere advanced monitor. should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Becton, Dickinson and Company. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Becton, Dickinson and Company should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Becton, Dickinson and Company directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
Frequently asked questions
- Is ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI c recalled?
- Yes. FDA lists a Class II recall by Becton, Dickinson and Company for ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI code: 00690103210927 The non-invasive ForeSight oximeter cable is intended for use as an adjunct monitor of absolute regional hemoglobin oxygen saturation of blood under the sensors in individuals at risk for reduced flow or no flow ischemic states. The ForeSight Oximeter Cable is also intended to monitor relative changes of total hemoglobin of blood under the sensors. The ForeSight Oximeter Cable is intended to allow for the display of StO2 and relative change in total hemoglobin on the HemoSphere advanced monitor., reported 20260930, with status "Ongoing." FDA recall number: Z-3250-2026.
- What is the recall class for Becton, Dickinson and Company's recall?
- FDA classified this recall as Class II. A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
- Why was ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI c recalled?
- FDA's recall record states the reason as: Due to incorrect switching of Channel 1 and 2 on the module and flag labels on the tissue oximetry cables.
- Who should I contact about this recall?
- Contact Becton, Dickinson and Company directly, or the distributor/pharmacy that supplied the product, to confirm whether your specific lot or unit is affected. Argus HQ aggregates the public FDA recall record and is not the recalling firm.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Becton Dickinson & CompanyCompiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Class II Recall: ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI… by Becton, Dickinson and Company. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/recall/becton-dickinson-and-z-3250-2026-2026-09-30
"FDA Class II Recall: ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI… by Becton, Dickinson and Company." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/recall/becton-dickinson-and-z-3250-2026-2026-09-30.
Argus HQ Research. "FDA Class II Recall: ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI… by Becton, Dickinson and Company." Digital Empire Holdings LLC. Accessed October 12, 2026. https://argushq.ai/recall/becton-dickinson-and-z-3250-2026-2026-09-30.
@misc{argushq_argushq_ai_recall_becton_dickinson_and_z_3250_2026_2026_09_30_2026,
title = {FDA Class II Recall: ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI… by Becton, Dickinson and Company},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/recall/becton-dickinson-and-z-3250-2026-2026-09-30},
note = {Accessed: October 12, 2026}
}Source: FDA.gov — Recalls ↗

